ライフサイエンスコーパス: fatality

1 th and indication for liver transplantation (fatality).

2 e inflammatory disease resulting in neonatal fatality.

3 e of a blood-fluid level with six-month case fatality.

4 dults with comorbidities and had higher case fatality.

5 resulting in muscle atrophy, paralysis, and fatality.

6 to pneumococcal and Hib meningitis NPNM case fatality.

7 mplementation was associated with lower case fatality.

8 a primary, a contributory, or no role in the fatality.

9 -related mortality but similar rates of case fatality.

10 ographics, clinical features, treatment, and fatality.

11 RV causes severe disease in humans with high fatality.

12 ent, such as habitat destruction or wildlife fatalities.

13 obal threat by rapid transmission and severe fatalities.

14 , age, gender and comorbidities for COVID-19 fatalities.

15 ions and has caused hundreds of thousands of fatalities.

16 nclude neurological disorders, sequelae, and fatalities.

17 The outbreak resulted in two fatalities.

18 been associated with numerous overdoses and fatalities.

19 s with drug overdose deaths and other injury fatalities.

20 th millions infected and more than 1 million fatalities.

21 e fatality 7.0%) and 48/211(23% deaths, case fatality 1.4% ) met criteria for severe malaria and non-

22 gens, is an emerging phlebovirus with a high fatality(1-4).

23 or 12F (1042/1994 [52.3%]), and higher case fatality (212/1128 [18.8%]) compared to 8.6% (291/3365)

24 were adult males (68%), but the highest case fatality (39%) was seen in children aged younger than 5

25 a admissions died; 163/211 (77% deaths, case fatality 7.0%) and 48/211(23% deaths, case fatality 1.4%

26 Fatalities after AMI were related to a high incidence of

27 many jurisdictions, the decline of cases and fatalities after apparent epidemic peaks has not been ra

28 nificantly associated with lower 30-day case fatality after ICH.

29 vid-19 occurred in 30 participants, with one fatality; all 30 were in the placebo group.

30 atal and nonfatal CHD incidence and CHD case-fatality among blacks and whites in the Atherosclerosis

31 of the leading causes of transfusion-related fatalities and is characterized by the onset of acute re

32 lides modify the natural landscape and cause fatalities and property damage worldwide.

33 associated with high risks of birth defects/fatality and adverse long-term postnatal health.

34 rived from pathogen-specific meningitis case fatality and bacterial meningitis case data from surveil

35 This study aimed to report the incidence, fatality and canine risk factors of heat-related illness

36 tors associated with poor maternal outcomes (fatality and composite of fatality or permanent neurolog

37 mainly due to decreases in age-related case fatality and disease severity.

38 Considering looming fatality and economic recession, effective policy making

39 We assessed case fatality and functional outcome in patients treated cons

40 aking economic losses and caused hundreds of fatalities, and for many represents a presage of what th

41 re the leading causes of transfusion-related fatalities, and specific therapies are unavailable.

42 rstood and factors associated with severity, fatality, and survival remain elusive.

43 013 strain in the Netherlands, its high case fatality, and the availability of a safe and effective v

44 millions of people and causes almost 600,000 fatalities annually.

45 No fatalities are observed at a paclitaxel dose equal to th

46 ARS-CoV-2) that has caused more than 922,000 fatalities as of 13 September 2020.

47 ogistic regression model was performed using fatality as the binomial dependent variable and treatmen

48 Case fatality at discharge was 21% (95% CI 17% to 25%) after

49 We compared 30-day case fatality before, during, and after bundle implementation

50 as the number one cause of childhood cancer fatalities, but demographic and socioeconomic disparitie

51 10 million infections and more than 500,000 fatalities by June 2020.

52 enerally, but neurological sequelae and even fatalities can occur, especially in severe forms that mi

53 urse is less severe, resulting in lower case fatality compared with nonrecurrent meningitis patients.

54 driven by the fear of a severe reaction and fatalities continue to occur.

55 etric shape of model-predicted incidence and fatality curves is consistent with observations from man

56 also call for countries to provide case and fatality data disaggregated by age and sex to improve re

57 management of the disease, in line with case fatality data from cohort studies.

58 ced by a symmetry analysis of US state-level fatality data.

59 syncytial viral" combined with "mortality", "fatality", "death", "died", "deaths", or "CFR" for artic

60 ica with almost 30,000 cases and over 11,000 fatalities, devastatingly affecting Guinea, Liberia, and

61 Here we explore a model of fatality-driven awareness in which individual protective

62 platforms that differentiated survivors and fatalities early after infection.

63 Marburg virus (MARV), have also caused high fatality epidemics.

64 gitis deaths and state-level meningitis case fatality estimates.

65 of tuberculosis resulting in over 1 million fatalities every year, despite decades of research into

66 ldren older than 6 months was high, but case fatality following SAM was 1.2%, much lower than the 10%

67 lict fatalities (mean +/- SD: 1.41 +/- 10.21 fatalities) for children living in rural areas during th

68 combat casualties, patterns of injury among fatalities from explosive mechanisms were associated wit

69 The alarming global rise in fatalities from multidrug-resistant Staphylococcus aureu

70 ation in eclampsia and maternal and neonatal fatality from hypertensive disorders of pregnancy betwee

71 Recent data suggest that case fatality from severe acute malnutrition (SAM) in India m

72 h subsequently higher COVID-19 infection and fatality growth rates in pro-Trump counties.

73 Many of these fatalities have been linked to exposure to high levels o

74 mechanical ventilation, and in-hospital case fatality (hCFR) among children with BPD compared with th

75 vailable population data on COVID-19 related fatalities, IFRs for patients age 70 years or older and

76 iovascular diseases are the leading cause of fatalities in the United States.

77 human pathogen, HAdV-B76, associated with a fatality in 1965, shows a remarkable degree of genome id

78 o identify cerebral features associated with fatality in Asian adults.

79 uliar trend of milder disease and lower case fatality in children compared with adults.

80 nza-MRSA coinfection is associated with high fatality in critically ill children.

81 to -3.7, p = 0.003) reduction in 30-day case fatality in difference-in-difference analysis.

82 Yet, deletion of the CR causes neonatal fatality in mice, implying the CR possesses a protective

83 ey challenge in reducing the number of these fatalities is to make Search and Rescue (SAR) algorithms

84 rferon (IFN) receptor signaling, TLR9-driven fatality is dependent on IFN-gamma receptor signaling.

85 talized in the intensive care unit, the case fatality is up to 40%.

86 both culture sites positive had higher case-fatality, longer lengths of stay, and higher costs than

87 la virus IgG seropositive) and report a case fatality lower than previously reported (55.6% vs 100% i

88 Exposure to 5 localized civil conflict fatalities (mean +/- SD: 1.41 +/- 10.21 fatalities) for

89 data sources on incidence, prevalence, case fatality, mortality, and health risks to produce estimat

90 dehydrogenase, and creatinine correlated to fatality (odds ratios [ORs], 2.9, 3.4, 5.8, and 31.9; al

91 ic, and 0.5% septicemic with associated case fatalities of 14.2%, 31.1%, and 20.0%, respectively.

92 Ebola, a hypervariable RNA virus causing fatalities of up to 90% for recent outbreaks in Africa,

93 ne who was asymptomatic, resulting in a case fatality of 55.6% (95% CI 30.8-78.5) for adults.

94 us rehydration therapy have reduced the case fatality of cholera from more than 50% to much less than

95 apid sociodemographic improvements, the case fatality of injuries has declined, which could be attrib

96 Beyond the fear and fatality of the virus itself comes a likely wave of psyc

97 maternal outcomes (fatality and composite of fatality or permanent neurological injury) amongst women

98 investigate the consistency of infection and fatality patterns across multiple countries.

99 us-induced MMEs involved a greater number of fatalities per event compared to other pathogens.

100 sters, notably weight loss, viral loads, and fatality (RAG2 KO only).

101 kaemia showed a significantly increased case-fatality rate (2.25, 1.13-4.57; p=0.023).

102 The EOD case fatality rate (71%) was higher than in LOD (32%) or cont

103 The suicide case-fatality rate (CFR)-the proportion of suicidal acts that

104 avirus 2 (SARS-CoV-2) are elderly, infection fatality rate (IFR) estimates for the age group 70 years

105 lity rate 7.0%) and 48/211 (23% deaths, case fatality rate 1.4%) met the criteria for severe malaria

106 %), of whom 27 had early-onset disease (case fatality rate 5.2%) and 26 had late-onset disease (case

107 d in 17 states, including seven deaths (case fatality rate 6%).

108 53 infants died (case fatality rate 6.2%), of whom 27 had early-onset disease

109 with malaria died; 163/211 (77% deaths, case fatality rate 7.0%) and 48/211 (23% deaths, case fatalit

110 te 5.2%) and 26 had late-onset disease (case fatality rate 7.7%).

111 There were 31 deaths (case fatality rate [CFR], 6.2% [95% confidence interval, 4.3%

112 Case fatality rate among patients who received monotherapy wi

113 t emerged in 2013 was associated with a high fatality rate and may become a long-term threat to publi

114 s Ebola virus disease (EVD), which carries a fatality rate between 25% and 90% in humans.

115 Case fatality rate by antimicrobial regimen was calculated.

116 Case fatality rate did not substantially differ between patie

117 virus 2 (SARS-CoV-2) prevalence and the case-fatality rate during hospital admission.

118 ed 1-year age- and comorbidity-adjusted case fatality rate for a 65-year-old patient decreased in wom

119 The case-fatality rate for COVID-19 varies markedly by age, rangi

120 The case fatality rate for residents was 33.7% (34 of 101).

121 Case fatality rate from typhoid-associated intestinal perfora

122 The case-fatality rate in favipiravir-treated patients was lower

123 causes severe hemorrhagic fever with a high fatality rate in humans in West and Central Africa.

124 The all-cause case-fatality rate in patients with cancer after SARS-CoV-2 i

125 was 0.04% (95% CI 0.04-0.05%), with an event fatality rate of 14.18% (95% CI 11.08 - 17.96%).

126 Despite a fatality rate of 40%, the pathogenesis of HPS is poorly

127 Penicillin was associated with a case fatality rate of 75%.

128 c ductal adenocarcinoma has the highest case-fatality rate of any solid tumour, highlights the urgenc

129 oronavirus (named SARS-CoV-2) and has a case fatality rate of approximately 2%, started in Wuhan (Chi

130 fever, a viral hemorrhagic fever with a case fatality rate of approximately 30% in Africa.

131 that appear to be associated with high case fatality rate of these coronaviruses as well as the host

132 out of 2 319 066 confirmed cases, at a Case Fatality Rate of ~6.8%.

133 Corresponding BCG versus control case-fatality rate RRs were 0.58 (95% CI, .35-.94), 0.56 (.35

134 atory Syndrome (MERS) cases with a high case fatality rate stresses the need for the availability of

135 The case-fatality rate was 0.04%.

136 an aminoglycoside (n = 407 [53%]), the case fatality rate was 13%.

137 The in-hospital case-fatality rate was 17% (247/1479).

138 The case fatality rate was 20% overall.

139 After a mean follow-up of 44 days, the fatality rate was 26.3%.

140 The case fatality rate was 29.1% (122/419).

141 edian follow-up of 16 days, the overall case fatality rate was 33%, though 25% remain admitted.

142 Pneumococcal meningitis case fatality rate was 6-fold higher than that of meningococc

143 The case-fatality rate was 91%; 2 cases survived.

144 hs (interquartile range, 12-72) and the case fatality rate was highest in those unconscious (44.4%).

145 The highest fatality rate was in suicide injuries (62.6%).

146 suspected meningitis cases and deaths (case fatality rate) progressively declined from 2534 to 1359

147 miological parameters (such as the infection fatality rate), does not include importation or subnatio

148 D-19 diagnosis did not impact survival (case fatality rate, 34% vs 35%), though the BTKi was held dur

149 eaths can be estimated by 4 approaches: case-fatality rate, infection-related mortality, and excess m

150 rays, as a means of reducing the high cancer fatality rate, is discussed.

151 urring throughout Saudi Arabia at a 38% case fatality rate, with the potential for worldwide spread v

152 avirus disease (COVID-19) with a significant fatality rate.

153 another coronavirus, SARS-CoV-2, with a high fatality rate.

154 he relationship between pathogens and 60-day fatality rate.

155 Disease carried a high case-fatality rate.

156 th checkpoint inhibitor regimens, with a 19% fatality rate.

157 ntestinal disease resulting in a significant fatality rate.

158 erval, 18.7-34.1) with no change in the case-fatality rate.

159 th diagnostic challenge and a high potential fatality rate.

160 EVD has a high case-fatality rate; it is characterized by fever, gastrointes

161 in coronavirus disease 2019 (COVID-19) case-fatality rates (CFRs) across countries, leading to uncer

162 ression analyses to explore patterns in case-fatality rates (CFRs) at 30 days and 1 year and to explo

163 Case fatality rates (CFRs) during 2010-2017 were calculated u

164 ay face increased acquisition risks and case fatality rates (CFRs).

165 , and multiorgan failure with up to 33% case fatality rates (CFRs).

166 ymptoms at disease onset and calculated case fatality rates (CFRs).

167 panic White populations, but not higher case-fatality rates (mostly reported as in-hospital mortality

168 a population may help explain differences in fatality rates across countries and how transmission unf

169 n were found to have a significant impact on fatality rates after taking into account the age and com

170 ed pathogen, is an emerging phlebovirus, and fatality rates among those infected with this virus are

171 c threat because of its associated high case-fatality rates and capacity for human-to-human transmiss

172 ty was assessed by means of in-hospital case-fatality rates and compared by group as cohort study ris

173 There were significantly elevated case fatality rates and elevated liver transaminase levels in

174 syndrome-coronavirus 2) is resulting in high fatality rates and incapacitated health systems.

175 uses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential.

176 The high case-fatality rates and potential for use as a biological wea

177 Case fatality rates are estimated to be in the 30% range, and

178 Cardiovascular (CV) disease fatality rates are higher for women compared with men wi

179 In high-burden settings, case fatality rates are reported to be between 11% and 32% in

180 e, and shock culminating in death, with case fatality rates as high as 90%.

181 dly positively associated with COVID-19 case fatality rates at the country level, the opposite is gen

182 ed with devastating human disease, with case fatality rates averaging 30%.

183 Case fatality rates below 6% have now been recorded in three

184 Patient fatality rates even with parenteral artesunate treatment

185 rates with a roughly 2 week delay, and case fatality rates exhibit a positive feedback pattern.

186 Here, using a global dataset of >4,000 case-fatality rates for 65 infectious diseases (caused by mic

187 Pathogen-specific 60-day fatality rates for all pathogens were higher among child

188 Lower socioeconomic groups had higher case fatality rates for stroke and ischaemic heart disease, b

189 mission rates and greater reductions in case fatality rates for stroke and ischaemic heart disease.

190 Case fatality rates in severe falciparum malaria depend on th

191 Case fatality rates in west Africa were initially greater tha

192 septicemic (5%) plague, with associated case fatality rates of 17%, 27%, and 38%, respectively.

193 of encephalitis and respiratory illness with fatality rates of 50-100%.

194 cosides were associated with the lowest case fatality rates of all antimicrobials used for treatment

195 V) is a filovirus with documented human case-fatality rates of up to 90%.

196 tening illness in people and dogs, with high fatality rates ranging from 30 to 80%.

197 African American women also have case fatality rates related to preeclampsia 3 times higher th

198 that the numbers of documented cases and the fatality rates remain high in people, particularly durin

199 .09%), and North America (29.64%) while case fatality rates remained higher in the European temperate

200 eart disease, but greater reductions in case fatality rates than higher socioeconomic groups.

201 t risk of substantially higher COVID-19 case fatality rates than those currently seen in high-income

202 d social mobility on doubling rates and case fatality rates through a time-varying regression model.

203 Marburg virus (MARV) disease is lethal, with fatality rates up to 90%.

204 Case fatality rates were 1.1% (12/1,098) for MAM and 1.2% (6/

205 ucture estimates and age-dependent infection-fatality rates were applied to calculate the number of d

206 by the World Health Organization, has 12-30% fatality rates with a characteristic thrombocytopenia sy

207 annual hospital admission rates, 28-day case fatality rates, and mean length of stay for stroke, isch

208 can be difficult to treat and have high case-fatality rates, in part due to emergence of strains resi

209 diagnosis conversion rates and COVID-19 case-fatality rates, we also estimated the survival increment

210 ing outbreaks of disease with very high case fatality rates.

211 continues to cause outbreaks with high case fatality rates.

212 ics and management contributing to high case-fatality rates.

213 fore doing cross-country comparisons of case-fatality rates.

214 ics and management contributing to high case-fatality rates.

215 amyxovirus and zoononis with very high human fatality rates.

216 an (SUDV) cause human disease with high case fatality rates.

217 respiratory disease in humans with high case fatality rates.

218 hat causes sporadic outbreaks with high case fatality rates.

219 public health concern and lead to high case fatality rates.

220 more insight than ever before into the case fatality ratio (CFR) and how it varies with age and othe

221 ted have provided more insight into the case fatality ratio (CFR) and how it varies with age and othe

222 utbreak in Mongolia suggested increased case fatality ratio (CFR) in the second of 2 waves.

223 hospital admission rate and in-hospital case-fatality ratio (CFR) of pneumonia in older adults, strat

224 The case-fatality ratio (CFR), calculated from total numbers of r

225 , hospitalization rate, and in-hospital case-fatality ratio (hCFR) of RSV-ARI in older adults, strati

226 ase-fatality ratio (sCFR), and the infection-fatality ratio (IFR) in different geographic locations.

227 e ratio, 2.8; 95% CI, 1.9-4.1), and the case-fatality ratio (risk ratio [RR], 16.5; 95% CI, 13.7-19.8

228 es and examine the CFR, the symptomatic case-fatality ratio (sCFR), and the infection-fatality ratio

229 nonmeningeal IMD, and there is a higher case-fatality ratio associated with these non-A serogroups; h

230 recorded MVD outbreak with the highest case-fatality ratio happened in 2005 in Angola, where direct

231 The mean projected case-fatality ratio in 2016-2030 was 1.3% (0.4-3.7).

232 n epidemiologic weeks 9 and 17 with 15% case fatality ratio in the health district of Ouelessebougou,

233 We estimate that the infection fatality ratio is lowest among 5-9-year-old children, wi

234 US surveillance data suggest that the case fatality ratio is substantially higher in children with

235 as 0.8/1000 (95% CI, 0-1.7/1000) with a case-fatality ratio of 1.8%.

236 r prediction model, resulting in a mean case-fatality ratio of 2.2% (95% CI 0.7-4.5) in 1990-2015.

237 sible for over 2,300 infections, with a case fatality ratio of approximately 35%.

238 In community-based settings, the mean case-fatality ratio was 1.5% (0.5-3.1) compared with 2.9% (0.

239 (32 of 60) were hospitalized, the infection-fatality ratio was 20.0% (12 of 60), the case-fatality r

240 atality ratio was 20.0% (12 of 60), the case-fatality ratio was 31.6% (12 of 38), and the inpatient m

241 (25 of 33) were hospitalized, the infection-fatality ratio was 33.3% (11 of 33), the case-fatality r

242 atality ratio was 33.3% (11 of 33), the case-fatality ratio was 39.2% (11 of 28), and inpatient morta

243 The case fatality ratio was 83.3%.

244 incubation period was 10 days, and the case fatality ratio was 83.3%.

245 cases enrolled, we identified 6 deaths (case-fatality ratio, .07%; 95% CI, .01-.13%), 2 from Nepal, 4

246 We described case fatality ratios (CFRs), pathogen distribution, and annua

247 spital admission rates, and in-hospital case-fatality ratios (hCFRs) of human metapneumovirus-associa

248 develop a prediction model to estimate case-fatality ratios across heterogeneous groupings, and to p

249 Case-fatality ratios for measles have seen substantial declin

250 We extracted data on case-fatality ratios for measles overall and by age, where po

251 eneous groupings, and to project future case-fatality ratios for measles up to 2030.

252 from 1990 to 2015 and projected future case-fatality ratios for measles up to 2030.

253 , we aimed to update the estimations of case-fatality ratios for measles, to develop a prediction mod

254 den is highly dependent on estimates of case-fatality ratios for measles, which can vary according to

255 ed a best-fit model to estimate measles case-fatality ratios from 1990 to 2015 and projected future c

256 analysis to produce pooled estimates of case fatality ratios from the included studies, which we divi

257 Case fatality ratios in children with tuberculosis are poorly

258 ing hospital admissions and in-hospital case-fatality ratios of influenza virus ALRI.

259 Case fatality ratios spanned 0.05% at ages of 5 to 17 years t

260 study provides an updated estimation of case-fatality ratios that could help to refine assessment of

261 With imprecise case-fatality ratios, there is continued uncertainty about th

262 ematic review evidence on corresponding case-fatality ratios.

263 heterogeneity between countries in infection fatality ratios.

264 ics usually increased from low levels before fatalities reached an initial peak.

265 se decreased over the study period, but case fatality remained high.

266 independent markers of disease severity and fatality, respectively.

267 Cancer fatalities result from metastatic dissemination and ther

268 corresponding crude or naive confirmed case fatality risk (2,169/48,557 = 4.5%) and the approximator

269 e estimate that the overall symptomatic case fatality risk (the probability of dying after developing

270 ropathy, which are associated with increased fatality risk, are due to diphtheria toxin, an exotoxin

271 istochemical studies of lung tissue from one fatality show sub-anatomical distributions of SARS-CoV-2

272 calculate in-hospital sepsis-associated case-fatality, stratified by underlying GBD cause.

273 963 eruption which caused more than thousand fatalities, suggests a vertically and laterally intercon

274 antially higher for KT recipients (eg, >=50% fatality) than for waitlist registrants.

275 Importantly, CV-ADR were associated with fatalities that ranged from ~10% (SVAs and ventricular a

276 y disease were most frequent in the COVID-19 fatalities, that the burden of disease was low, and that

277 The tsunami caused at least 437 fatalities, the greatest number from a volcanically-indu

278 reases in the overall global rate of suicide fatalities, this trend is not reflected everywhere.

279 ment about their study linking motor vehicle fatalities to the transition to Daylight Saving Time.

280 atio of pneumococcal and Hib meningitis case fatality to pneumococcal and Hib meningitis NPNM case fa

281 ence was estimated by applying modelled case-fatality to sepsis-related mortality estimates.

282 mating order-of-magnitude individual risk of fatality under certain basis conditions.

283 Overall case fatality was 20.9%.

284 71 [22%]), or fluoroquinolone (n = 61 [8%]), fatality was 23%, 10%, and 12%, respectively.

285 =6 months after conservative treatment, case fatality was 30% (95% CI 25% to 30%) and favourable func

286 to 50%) and after haematoma evacuation, case fatality was 34% (95% CI 30% to 38%) and 42% (95% CI 37%

287 ns prior to death in 1 patient; however, the fatality was attributed to underlying disease per the re

288 (interquartile range, 12-72) months and case fatality was highest in those unconscious (44.4%).

289 In-hospital sepsis-associated case-fatality was modelled for each location using linear reg

290 stribution of mobility, hospitalization, and fatality, we conclude that verifiable evidence exists to

291 Although fatalities were not observed, SARS-CoV-2-infected ferret

292 VIT proved to be safe and no fatalities were recorded in the studies included in this

293 No life-threatening adverse events or fatalities were reported.

294 antimicrobials, maternal mortality and fetal fatality were 29% and 62%, respectively; for untreated c

295 ntreated cases, maternal mortality and fetal fatality were 67% and 74%, respectively.

296 us clearance is essential for preventing the fatality when the infection has progressed to the CNS.

297 l-web spiders are infamous for causing human fatalities, which are induced by venom peptides known as

298 focusing on differences in age-adjusted case fatality will be essential for accurately comparing coun

299 -in-difference analysis compared 30-day case fatality with 32,295 patients with ICH from 214 other ho

300 nd continue to cause an increasing number of fatalities worldwide.